Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yidong Wang
Guangzhou Medical University - Department of Thoracic Surgery and Oncology
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
135
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Safety of Immune Checkpoint Inhibitors for Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer Who Progressed on EGFR Tyrosine Kinase Inhibitors: A Systematic Review, Meta-Analysis, and Network Meta-Analysis
Number of pages: 48
Posted: 27 Feb 2024
Yi Zhao
,
Ying He
,
Wei Wang
,
Qi Cai
,
Fan Ge
,
Zisheng Chen
,
Hongsheng Deng
,
Shen Lao
, Yidong Wang,
Wenhua Liang
and
Jianxing He
Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - Department of Thoracic Surgery and Oncology, Guangzhou Medical University - Department of Thoracic Surgery and Oncology and Guangzhou Medical University - Department of Thoracic Surgery and Oncology
Downloads
135
(551,165)
View PDF
Download
Abstract:
Non-small-cell lung cancer, immune checkpoint inhibitor, EGFR, meta-analysis
Feedback